CBRN Medical Countermeasure PBA Opens a Pathway for Therapeutics, Diagnostics, and Development Partners

The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is inviting organizations to join its CBRN Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. The announcement seeks therapeutic developers, diagnostic innovators, and development support organizations to help accelerate the development, testing, and fielding of next-generation medical defense capabilities. The PBA establishes

CBRN Medical Countermeasure PBA Opens a Pathway for Therapeutics, Diagnostics, and Development Partners Read More »